Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetic Regulation of Lipid Pathways Contributing to Non-alcoholic Fatty Liver and Atherogenic Dyslipidemia

NCT04209816 is registered in ClinicalTrials.gov with Marja-Riitta Taskinen as lead sponsor.

NCT NCT04209816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04209816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetic Regulation of Lipid Pathways Contributing to Non-alcoholic Fatty Liver and Atherogenic Dyslipidemia
Lead sponsor
Marja-Riitta Taskinen
Phase
Observational
Overall status
Enrolling by invitation
Start date
December 1, 2019
Completion date
December 31, 2028
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atherogenic dyslipidemia, insulin resistance, non-alcoholic fatty liver